Drug survival of guselkumab in patients with plaque psoriasis: A 2 year retrospective, multicenter study

by Yuliya Lytvyn, PhD, Hiba Zaaroura, MD, Asfandyar Mufti, MD, Shaikhah AlAbdulrazzaq, MD, Jensen Yeung, MD, FRCPC
Published 2021-09-01

Secukinumab dose optimization in adult psoriasis patients: A retrospective, multicenter case series

by Michelle Phung, BMSc, Jorge R. Georgakopoulos, BSc, Arvin Ighani, BMSc, Lyne Giroux, MD, FRCPC, Jensen Yeung, MD, FRCPC
Published 2018-05-01

Treatment outcomes in patients with papuloerythroderma of Ofuji: A systematic review

by Asfandyar Mufti, MD, Yuliya Lytvyn, PhD, Abrahim Abduelmula, BScN, Patrick Kim, BHSc, Muskaan Sachdeva, BHSc, Jensen Yeung, MD, FRCPC
Published 2021-06-01

A systematic review of vitiligo onset and exacerbation in patients receiving biologic therapy

by Muskaan Sachdeva, BHSc, Asfandyar Mufti, MD, Nadia Kashetsky, MSc, Jorge R. Georgakopoulos, MD, Sheida Naderi-Azad, BSc, Jennifer Salsberg, MD, FRCPC, Jensen Yeung, MD, FRCPC
Published 2021-03-01

Clinical manifestations and treatment outcomes in prurigo pigmentosa (Nagashima disease): A systematic review of the literatureCapsule Summary

by Asfandyar Mufti, MD, Sara Mirali, PhD, Abrahim Abduelmula, BScN, Katherine Ann McDonald, MD, Shaikhah Alabdulrazzaq, BMBCh, Muskaan Sachdeva, BHSc, Jensen Yeung, MD, FRCPC
Published 2021-06-01

Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study

by Jorge R. Georgakopoulos, MD, Tina Felfeli, MD, Aaron M. Drucker, MD, ScM, FRCPC, Christine E. Jo, BSc, Vincent Piguet, MD, PhD, FRCP, Jensen Yeung, MD, FRCPC
Published 2021-09-01